Acute pulmonary embolism (PE) is a fairly common condition that affects 1-2/1000 individuals in the US per year. Patients with massive PE (defined by hemodynamic compromise) have high mortality and these patients benefit from aggressive treatments such as thrombolysis, surgical thrombectomy and catheter-based interventions. However, which modality is superior is not known.
The PERT (Pulmonary Embolism Response Team) Registry is a national registry that collect data on patients admitted to the hospital with PE for whom a pulmonary embolism response team (PERT) meeting occurs to help guide management. Initially begun at Massachusetts General Hospital, Michigan Medicine was invited in 2018 to collaborate in this multi-center registry. Data collected in that registry include vital signs, comorbidities, treatment decisions, and outcomes during the hospital stay and in follow-up. This information is important for advancing the science of acute PE management and for helping the Michigan Medicine PERT team understand how their management decisions are similar and/or different to national treatment patterns.
The PERT Registry Leaders hope to advance the understanding of practices used and outcomes of specific PE treatment by using epidemiologic, therapeutic, quality assessment and outcomes research.